financetom
Business
financetom
/
Business
/
Von der Leyen to outline EU priorities after US trade deal backlash
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Von der Leyen to outline EU priorities after US trade deal backlash
Sep 9, 2025 3:22 PM

STRASBOURG (Reuters) -The European Union's chief executive, Ursula von der Leyen, sets out her priorities for the year ahead on Wednesday after a bruising summer dominated by a much-criticised trade deal with U.S. President Donald Trump.

Von der Leyen, the president of the European Commission, will address the European Parliament in Strasbourg with her State of the Union speech - an annual opportunity to set the political agenda of the 27-nation bloc. It is scheduled for 9 a.m. CEST (0700 GMT).

The German former defence minister secured a second five-year term last year and pledged to focus on building up Europe's defences in the face of growing fears about Russia and on boosting the continent's economic competitiveness.

She has also championed strong support for Ukraine through continued financial aid and more EU sanctions on Moscow.

But she faced considerable criticism over the trade deal she agreed with Trump at his Turnberry Scottish golf resort in July.

Under that deal, the EU agreed to remove tariffs on U.S. industrial goods, ease access for U.S. farm products, and accept a 15% U.S. tariff on most of its exports, compared to mostly low single-digit or no duties before Trump began his second term. 

Many European politicians and commentators blasted the deal as unbalanced in favour of the U.S., and France's then-Prime Minister Francois Bayrou branded it an act of submission. 

EU officials said it was the best deal they could get, avoided a trade war, and provided vital certainty for European businesses. It also reflected an unwillingness among leaders of EU countries to escalate tensions with Trump, particularly given Washington's key role in Europe's security.

Alberto Alemanno, a professor of EU law at the HEC Paris business school, said other EU leaders were "scapegoating" von der Leyen for their own shortcomings.

"True: von der Leyen embodies EU weaknesses, yet those aren't of her making. Alone she can't retaliate against the US, act decisively on Gaza, or broker Ukraine talks," he said on X.

BUREAUCRACY BATTLE

Von der Leyen's Commission has proposed a raft of policies this year to cut bureaucracy for struggling industries and help European firms compete with rivals in China and the U.S.

Some industries have welcomed those moves, but others say the Commission has done too little to implement a competitiveness blueprint drawn up by former European Central Bank President Mario Draghi to improve productivity and investment in Europe. 

"I don't think we have yet seen the step change in this space that Draghi called for, and I'm not sure that is only the fault of the Commission," said Simone Tagliapietra, senior fellow at think tank Bruegel, adding that national governments also bear responsibility.

But her efforts to simplify EU bureaucracy have been criticised by left-wing EU lawmakers and campaigners as weakening environmental laws and corporate accountability.

A group of 470 non-governmental organisations issued a statement ahead of her speech denouncing her Commission's "deregulation campaign."

(Writing and reporting by Andrew Gray in Brussels and Kate Abnett in Strasbourg;Editing by Rod Nickel)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Physical Therapy Reports Change in 2024 Medicare Rate Reduction
US Physical Therapy Reports Change in 2024 Medicare Rate Reduction
Mar 11, 2024
09:36 AM EDT, 03/11/2024 (MT Newswires) -- US Physical Therapy ( USPH ) said Monday that the 2024 Medicare rate reduction for therapy services will be roughly 1.8%, compared with 3.5% previously. The change was made in the Consolidated Appropriations Act, 2024, signed into law on March 8, the physical therapy clinics company added. The rate change will raise full-year...
US FDA approves Novo Nordisk's Wegovy for lowering heart risks
US FDA approves Novo Nordisk's Wegovy for lowering heart risks
Mar 11, 2024
(Reuters) -The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss drug Wegovy on Friday for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes. Novo's widely used diabetes drug Ozempic and weight-loss drug Wegovy, both chemically known as semaglutide, belong to a class of drugs called GLP-1 agonists. Originally developed...
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
Mar 11, 2024
Monday, Aprea Therapeutics Inc ( APRE ) announced that the FDA has cleared its Investigational New Drug (IND) application for APR-1051. “APR-1051 is a next-generation inhibitor of WEE1 kinase, and based on its unique characteristics, we believe it will be best in class,” said Oren Gilad, President and CEO of Aprea. “We look forward to evaluating therapeutic activity in patients, focusing on Cyclin...
WisdomTree Reports February Net Flows of $512 Million
WisdomTree Reports February Net Flows of $512 Million
Mar 11, 2024
09:37 AM EDT, 03/11/2024 (MT Newswires) -- WisdomTree ( WT ) reported February net flows Monday of $512 million, bringing total assets under management to about $102.86 billion. The company said its cryptocurrency product suite reached more than $100 million of annual net inflows, contrbuting to roughly $700 million in AUM at the month's end. Price: 8.5, Change: +0.08, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved